{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:13:06Z","timestamp":1790673186946,"version":"4.1.0"},"reference-count":99,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Congestion drives most hospitalizations for acute and chronic heart failure (HF), reflecting the pivotal role of sodium and water retention in disease progression. Loop diuretics remain the first-line decongestive therapy, yet up to one-third of patients exhibit an inadequate natriuretic response\u2014defined as diuretic resistance (DR)\u2014which is strongly associated with prolonged hospitalization, readmissions and adverse outcomes. DR is a multifactorial phenomenon arising from pharmacokinetic limitations, tubular adaptations, neurohormonal activation, and hemodynamic disturbances. Impaired renal perfusion, elevated venous pressures, and chloride depletion are key contributors that mutually reinforce one another and blunt diuretic efficacy. Early recognition through urinary sodium measurement and urine output monitoring is essential to guide therapy before resistance becomes entrenched. Beyond optimizing loop diuretic delivery, management strategies should include sequential nephron blockade, correction of electrolyte and acid\u2013base imbalances and avoidance of excessive sodium restriction. Certain patient phenotypes\u2014right heart failure (RHF), advanced chronic kidney disease (CKD), obesity-related HF with preserved ejection fraction (HFpEF), and frail or elderly patients\u2014pose additional challenges due to overlapping mechanisms of resistance and increased treatment vulnerability. Each requires a tailored approach that balances decongestion with preservation of renal function and systemic perfusion. In refractory cases, extracorporeal fluid removal or peritoneal dialysis may be necessary, while newer pharmacologic agents\u2014such as sodium\u2013glucose cotransporter 2 inhibitors (SGLT2i), mineralocorticoid receptor antagonists (MRAs), and glucagon-like peptide-1 receptor agonists GLP-1 RAs)\u2014offer complementary benefits. This review synthesizes mechanistic insights, bedside monitoring tools and phenotype-specific strategies for the management of DR in cardiorenal syndrome (CRS).<\/jats:p>","DOI":"10.3389\/fcvm.2025.1731305","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T06:38:07Z","timestamp":1767595087000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Diuretic resistance in cardiorenal syndrome: mechanisms, monitoring and phenotype-tailored management"],"prefix":"10.3389","volume":"12","author":[{"given":"Georgios","family":"Aletras","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Bachlitzanaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Stratinaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Foukarakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Petrakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannis","family":"Pantazis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michalis","family":"Hamilos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kostas","family":"Stylianou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"2021","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"B2","doi-asserted-by":"publisher","first-page":"695547","DOI":"10.3389\/fcvm.2021.695547","article-title":"Improving diuretic response in heart failure by implementing a patient-tailored variability and chronotherapy-guided algorithm","volume":"8","author":"Kenig","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/ejhf.1369","article-title":"The use of diuretics in heart failure with congestion\u2014a position statement from the heart failure association of the European Society of Cardiology","volume":"21","author":"Mullens","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.jacc.2019.12.059","article-title":"Diuretic therapy for patients with heart failure: JACC state-of-the-art review","volume":"75","author":"Felker","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"4470","DOI":"10.3390\/jcm13154470","article-title":"Diuretic treatment in heart failure: a practical guide for clinicians","volume":"13","author":"Wu","year":"2024","journal-title":"J Clin Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s11739-018-02019-7","article-title":"Prevalence and outcome of diuretic resistance in heart failure","volume":"14","author":"Trull\u00e0s","year":"2019","journal-title":"Intern Emerg Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3390\/kidneydial3010005","article-title":"Renal mechanisms of diuretic resistance in congestive heart failure","volume":"3","author":"Lameire","year":"2023","journal-title":"Kidney Dial"},{"key":"B8","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.cardfail.2024.11.008","article-title":"Counterpoint: natriuresis-guided diuresis in patients admitted to hospital with heart failure\u2014barking up the wrong tree? Towards direct insights into the efficacy of diuretic therapy","volume":"31","author":"Maaten","year":"2025","journal-title":"J Card Fail"},{"key":"B9","doi-asserted-by":"publisher","first-page":"954","DOI":"10.34067\/KID.0006372021","article-title":"Classic and novel mechanisms of diuretic resistance in cardiorenal syndrome","volume":"3","author":"Cox","year":"2022","journal-title":"Kidney360"},{"key":"B10","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1159\/000546520","article-title":"Systematic review on the management of diuretic resistance in acute heart failure across the Spectrum of kidney disease","volume":"15","author":"Marques","year":"2025","journal-title":"Cardiorenal Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1161\/HYPERTENSIONAHA.120.15205","article-title":"Pathophysiology of diuretic resistance and its implications for the management of chronic heart failure","volume":"76","author":"Wilcox","year":"2020","journal-title":"Hypertension"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.3390\/jcm14092996","article-title":"A pragmatic approach to acute cardiorenal syndrome: diagnostic strategies and targeted therapies to overcome diuretic resistance","volume":"14","author":"Tran","year":"2025","journal-title":"J Clin Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1002\/ejhf.1753","article-title":"Clinical importance of urinary sodium excretion in acute heart failure","volume":"22","author":"Damman","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"B14","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s10741-019-09851-9","article-title":"Loop diuretic resistance complicating acute heart failure","volume":"25","author":"Cox","year":"2020","journal-title":"Heart Fail Rev"},{"key":"B15","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1161\/CIRCHEARTFAILURE.113.000895","article-title":"Loop diuretic efficiency: a metric of diuretic responsiveness with prognostic importance in acute decompensated heart failure","volume":"7","author":"Testani","year":"2014","journal-title":"Circ Heart Fail"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2932","DOI":"10.3390\/jcm9092932","article-title":"Six-month predictive value of diuretic resistance formulas in discharged heart failure patients after an acute decompensation","volume":"9","author":"Feola","year":"2020","journal-title":"J Clin Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1056\/NEJMra1703100","article-title":"Diuretic treatment in heart failure","volume":"377","author":"Ellison","year":"2017","journal-title":"N Engl J Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1053\/j.ajkd.2021.09.029","article-title":"Diuretics in states of volume overload: core curriculum 2022","volume":"80","author":"Novak","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"4067","DOI":"10.1002\/ehf2.13525","article-title":"Association between intestinal oedema and oral loop diuretic resistance in hospitalized patients with acute heart failure","volume":"8","author":"Ikeda","year":"2021","journal-title":"ESC Heart Fail"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jjcc.2024.06.005","article-title":"Treatment strategies for diuretic resistance in patients with heart failure","volume":"85","author":"Horiuchi","year":"2025","journal-title":"J Cardiol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1053\/j.ajkd.2020.03.023","article-title":"NSAIDs in CKD: are they safe?","volume":"76","author":"Baker","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1053\/j.ajkd.2016.08.027","article-title":"Diuretic resistance","volume":"69","author":"Hoorn","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.amjcard.2016.09.014","article-title":"Implications of Serum chloride homeostasis in acute heart failure (from ROSE-AHF)","volume":"119","author":"Grodin","year":"2017","journal-title":"Am J Cardiol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.jchf.2021.07.006","article-title":"Chloride in heart failure","volume":"9","author":"Zandijk","year":"2021","journal-title":"JACC Heart Fail"},{"key":"B25","doi-asserted-by":"publisher","first-page":"25","DOI":"10.31083\/j.rcm.2020.01.6","article-title":"The dynamic relationship between serum chloride and cardiorenal syndrome","volume":"21","author":"Kazory","year":"2020","journal-title":"Rev Cardiovasc Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s40119-021-00238-2","article-title":"Chloride in heart failure syndrome: its pathophysiologic role and therapeutic implication","volume":"10","author":"Kataoka","year":"2021","journal-title":"Cardiol Ther"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e003180","DOI":"10.1161\/CIRCHEARTFAILURE.116.003180","article-title":"Hypochloremia and diuretic resistance in heart failure: mechanistic insights","volume":"9","author":"Hanberg","year":"2016","journal-title":"Circ Heart Fail"},{"key":"B28","doi-asserted-by":"publisher","first-page":"100614","DOI":"10.1016\/j.xkme.2023.100614","article-title":"Serum chloride and heart failure","volume":"5","author":"Arora","year":"2023","journal-title":"Kidney Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.amjmed.2014.12.020","article-title":"Substantial discrepancy between fluid and weight loss during acute decompensated heart failure treatment","volume":"128","author":"Testani","year":"2015","journal-title":"Am J Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"3438","DOI":"10.1002\/ehf2.14883","article-title":"Spot urine sodium-to-creatinine ratio surpasses sodium in identifying poor diuretic response in acute heart failure","volume":"11","author":"Iwanek","year":"2024","journal-title":"ESC Heart Fail"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1002\/ejhf.2967","article-title":"Sodium\u2013glucose cotransporter-2 inhibitors in heart failure: potential decongestive mechanisms and current clinical studies","volume":"25","author":"Biegus","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"B32","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13089-024-00396-z","article-title":"Decoding VExUS: a practical guide for excelling in point-of-care ultrasound assessment of venous congestion","volume":"16","author":"Assavapokee","year":"2024","journal-title":"Ultrasound J"},{"key":"B33","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1159\/000539469","article-title":"Unlocking the potential of VExUS in assessing venous congestion: the art of doing it right","volume":"14","author":"Koratala","year":"2024","journal-title":"Cardiorenal Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.ijcard.2017.02.150","article-title":"Pulmonary congestion evaluated by lung ultrasound predicts decompensation in heart failure outpatients","volume":"240","author":"Miglioranza","year":"2017","journal-title":"Int J Cardiol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12882-025-04060-z","article-title":"Venous excess Doppler ultrasound assessment and loop diuretic efficiency in acute cardiorenal syndrome","volume":"26","author":"Abu-Naeima","year":"2025","journal-title":"BMC Nephrol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e578","DOI":"10.1161\/CIR.0000000000000560","article-title":"Evaluation and management of right-sided heart failure: a scientific statement from the American heart association","volume":"137","author":"Konstam","year":"2018","journal-title":"Circulation"},{"key":"B37","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ccl.2020.01.004","article-title":"Right heart failure and cardiorenal syndrome","volume":"38","author":"Tabucanon","year":"2020","journal-title":"Cardiol Clin"},{"key":"B38","doi-asserted-by":"publisher","first-page":"998382","DOI":"10.3389\/fcvm.2023.998382","article-title":"Right ventricular failure: current strategies and future development","volume":"10","author":"Monteagudo-Vela","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1161\/CIRCULATIONAHA.109.887570","article-title":"Effects of right ventricular ejection fraction on outcomes in chronic systolic heart failure","volume":"121","author":"Meyer","year":"2010","journal-title":"Circulation"},{"key":"B40","doi-asserted-by":"publisher","first-page":"869","DOI":"10.3390\/jcm13030869","article-title":"Approach to decompensated right heart failure in the acute setting","volume":"13","author":"Levitt","year":"2024","journal-title":"J Clin Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.hfc.2022.08.022","article-title":"How to treat right heart failure. Tips for clinicians in everyday practice","volume":"19","author":"Crisci","year":"2023","journal-title":"Heart Fail Clin"},{"key":"B42","doi-asserted-by":"publisher","first-page":"7041","DOI":"10.3390\/jcm11237041","article-title":"Heart failure and cardiorenal syndrome: a narrative review on pathophysiology, diagnostic and therapeutic regimens\u2014from a cardiologist\u2019s view","volume":"11","author":"Mitsas","year":"2022","journal-title":"J Clin Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e840","DOI":"10.1161\/CIR.0000000000000664","article-title":"Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American heart association","volume":"139","author":"Rangaswami","year":"2019","journal-title":"Circulation"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.3390\/healthcare12232464","article-title":"Hemodynamic effects of SGLT2 inhibitors in patients with and without diabetes mellitus\u2014a narrative review","volume":"12","author":"Brata","year":"2024","journal-title":"Healthcare"},{"key":"B45","first-page":"III175","article-title":"Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness","volume":"73","author":"Colucci","year":"1986","journal-title":"Circulation"},{"key":"B46","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1161\/CIRCULATIONAHA.116.022362","article-title":"Systemic consequences of pulmonary hypertension and right-sided heart failure","volume":"141","author":"Rosenkranz","year":"2020","journal-title":"Circulation"},{"key":"B47","article-title":"Treatment of right heart failure: Is there a solution to the problem?","volume-title":"e-J Cardiol Pract","author":"Mehmood","year":""},{"key":"B48","doi-asserted-by":"publisher","first-page":"24097","DOI":"10.1038\/s41598-021-03317-5","article-title":"The effect of levosimendan on right ventricular function in patients with heart dysfunction: a systematic review and meta-analysis","volume":"11","author":"Hu","year":"2021","journal-title":"Sci Rep"},{"key":"B49","doi-asserted-by":"publisher","first-page":"I2","DOI":"10.1093\/eurheartj\/suy039","article-title":"Use of levosimendan in acute heart failure","volume":"20","author":"Harjola","year":"2018","journal-title":"Eur Heart J Suppl"},{"key":"B50","doi-asserted-by":"publisher","first-page":"6408","DOI":"10.3390\/jcm11216408","article-title":"Use of levosimendan in patients with advanced heart failure: an update","volume":"11","author":"Masarone","year":"2022","journal-title":"J Clin Med"},{"key":"B51","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jacc.2008.05.068","article-title":"Importance of venous congestion for worsening of renal function in advanced decompensated heart failure","volume":"53","author":"Mullens","year":"2009","journal-title":"JACC"},{"key":"B52","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1016\/j.jacc.2017.03.528","article-title":"Extracorporeal ultrafiltration for fluid overload in heart failure","volume":"69","author":"Costanzo","year":"2017","journal-title":"JACC"},{"key":"B53","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1007\/s11897-022-00574-x","article-title":"Right heart function in cardiorenal syndrome","volume":"19","author":"Kramer","year":"2022","journal-title":"Curr Heart Fail Rep"},{"key":"B54","first-page":"323","article-title":"Hospital and intensive care unit management of decompensated pulmonary hypertension and right ventricular failure","volume-title":"Heart Fail Rev","author":"Yataco","year":"2016"},{"key":"B55","doi-asserted-by":"publisher","first-page":"sfaf185","DOI":"10.1093\/ckj\/sfaf185","article-title":"Decongestion in patients with advanced chronic kidney disease coexisting with heart failure","volume":"18","author":"Zoccali","year":"2025","journal-title":"Clin Kidney J"},{"key":"B56","doi-asserted-by":"publisher","first-page":"114058","DOI":"10.1016\/j.biopha.2022.114058","article-title":"Diuretic resistance in patients with kidney disease: challenges and opportunities","volume":"157","author":"Guo","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"B57","doi-asserted-by":"publisher","first-page":"757","DOI":"10.2215\/CJN.14591121","article-title":"Detecting and treating lung congestion with kidney failure","volume":"17","author":"Zoccali","year":"2022","journal-title":"Clin J Am Soc Nephrol CJASN"},{"key":"B58","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/ejhf.3244","article-title":"Dietary sodium and fluid intake in heart failure. A clinical consensus statement of the heart failure association of the ESC","volume":"26","author":"Mullens","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"B59","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s40119-020-00172-9","article-title":"Proposal for new classification and practical use of diuretics according to their effects on the Serum chloride concentration: rationale based on the \u201cchloride theory.\u201d","volume":"9","author":"Kataoka","year":"2020","journal-title":"Cardiol Ther"},{"key":"B60","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1159\/000502648","article-title":"Diuretic resistance in cardio-nephrology: role of pharmacokinetics, hypochloremia, and kidney remodeling","volume":"44","author":"Masella","year":"2019","journal-title":"Kidney Blood Press Res"},{"key":"B61","doi-asserted-by":"publisher","first-page":"e003109","DOI":"10.1161\/CIRCHEARTFAILURE.116.003109","article-title":"Hypochloremia, diuretic resistance, and outcome in patients with acute heart failure","volume":"9","author":"Ter Maaten","year":"2016","journal-title":"Circ Heart Fail"},{"key":"B62","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1161\/CIRCULATIONAHA.122.062486","article-title":"Decongestion with acetazolamide in acute decompensated heart failure across the Spectrum of left ventricular ejection fraction: a prespecified analysis from the ADVOR trial","volume":"147","author":"Martens","year":"2023","journal-title":"Circulation"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1093\/eurheartj\/ehad236","article-title":"Pre-treatment bicarbonate levels and decongestion by Acetazolamide: the ADVOR trial","volume":"44","author":"Martens","year":"2023","journal-title":"Eur Heart J"},{"key":"B64","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1093\/eurheartj\/ehad266","article-title":"Great debate: in patients with decompensated heart failure, Acetazolamide in addition to loop diuretics is the first choice","volume":"44","author":"Mullens","year":"2023","journal-title":"Eur Heart J"},{"key":"B65","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/eurheartj\/ehac689","article-title":"Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial","volume":"44","author":"Trull\u00e0s","year":"2023","journal-title":"Eur Heart J"},{"key":"B66","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1016\/j.jchf.2024.09.015","article-title":"Choosing the appropriate combination of diuretics for patients with heart failure and congestion","volume":"12","author":"Carrizales-Sep\u00falveda","year":"2024","journal-title":"JACC Heart Fail"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1093\/ndt\/gfae058","article-title":"Proximal versus distal diuretics in congestive heart failure","volume":"39","author":"Nardone","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1056\/NEJMoa2203094","article-title":"Acetazolamide In acute decompensated heart failure with volume overload","volume":"387","author":"Mullens","year":"2022","journal-title":"N Engl J Med"},{"key":"B69","doi-asserted-by":"publisher","first-page":"69","DOI":"10.14740\/cr1627","article-title":"Acetazolamide And hydrochlorothiazide in patients with acute decompensated heart failure: insights from recent trials","volume":"15","author":"Umeh","year":"2024","journal-title":"Cardiol Res"},{"key":"B70","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1093\/ckj\/sfac258","article-title":"Practical approaches to building up a cardiorenal clinic","volume":"16","author":"de la Espriella","year":"2023","journal-title":"Clin Kidney J"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1093\/ndt\/gfae004","article-title":"When to use spironolactone, eplerenone or finerenone in the spectrum of cardiorenal diseases","volume":"39","author":"Kobayashi","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"B72","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1093\/ehjcvp\/pvaa132","article-title":"Efficacy and safety of early initiation of eplerenone treatment in patients with acute heart failure (EARLIER trial): a multicentre, randomized, double-blind, placebo-controlled trial","volume":"8","author":"Asakura","year":"2022","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N Engl J Med"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1002\/ejhf.3369","article-title":"Time from admission to randomization and the effect of empagliflozin in acute heart failure: a post-hoc analysis from EMPULSE","volume":"26","author":"Ferreira","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"B75","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.medcli.2023.08.001","article-title":"Effectiveness of urea administration for the treatment of hyponatremia in heart failure","volume":"162","author":"Mart\u00ednez Gonz\u00e1lez","year":"2024","journal-title":"Med Clin (Barc)"},{"key":"B76","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.3390\/jcm14103315","article-title":"Effectiveness of urea and tolvaptan in the treatment of hypotonic hyponatremia","volume":"14","author":"Delgado-Cuesta","year":"2025","journal-title":"J Clin Med"},{"key":"B77","doi-asserted-by":"publisher","first-page":"685","DOI":"10.4330\/wjc.v9.i8.685","article-title":"Effects of hypertonic saline solution on body weight and serum creatinine in patients with acute decompensated heart failure","volume":"9","author":"Lafreni\u00e8re","year":"2017","journal-title":"World J Cardiol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s12325-015-0254-9","article-title":"Hypertonic saline in conjunction with high-dose furosemide improves dose\u2013response curves in worsening refractory congestive heart failure","volume":"32","author":"Paterna","year":"2015","journal-title":"Adv Ther"},{"key":"B79","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1056\/NEJMoa1210357","article-title":"Ultrafiltration in decompensated heart failure with cardiorenal syndrome","volume":"367","author":"Bart","year":"2012","journal-title":"N Engl J Med"},{"key":"B80","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/ejhf.2115","article-title":"Universal definition and classification of heart failure: a report of the heart failure society of America, heart failure association of the European Society of Cardiology, Japanese heart failure society and writing committee of the universal definition of heart failure","volume":"23","author":"Bozkurt","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"B81","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/ejhf.2377","article-title":"Uncoupling between intravascular and distending pressures leads to underestimation of circulatory congestion in obesity","volume":"24","author":"Obokata","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1016\/j.jacc.2025.05.008","article-title":"ACC Scientific statement on the management of obesity in adults with heart failure","volume":"86","author":"Kittleson","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/j.jchf.2018.08.007","article-title":"Pivotal role of excess intra-abdominal adipose in the pathogenesis of metabolic\/obese HFpEF\u2217","volume":"6","author":"Kitzman","year":"2018","journal-title":"JACC Heart Fail"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1002\/ejhf.3676","article-title":"Heart failure and obesity: translational approaches and therapeutic perspectives. A scientific statement of the heart failure association of the ESC","volume":"27","author":"Savarese","year":"2025","journal-title":"Eur J Heart Fail"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1093\/eurheartj\/ehaa823","article-title":"Pathophysiologic importance of visceral adipose tissue in women with heart failure and preserved ejection fraction","volume":"42","author":"Sorimachi","year":"2021","journal-title":"Eur Heart J"},{"key":"B86","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3390\/jcdd11070204","article-title":"Impact of obstructive sleep apnea and sympathetic nervous system on cardiac health: a comprehensive review","volume":"11","author":"Maniaci","year":"2024","journal-title":"J Cardiovasc Dev Dis"},{"key":"B87","doi-asserted-by":"publisher","first-page":"3254","DOI":"10.1093\/eurheartj\/ehae322","article-title":"Semaglutide and diuretic use in obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF-DM trials","volume":"45","author":"Shah","year":"2024","journal-title":"Eur Heart J"},{"key":"B88","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.cardfail.2019.09.015","article-title":"Adverse renal response to decongestion in the obese phenotype of heart failure with preserved ejection fraction","volume":"26","author":"Reddy","year":"2020","journal-title":"J Card Fail"},{"key":"B89","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.jchf.2025.03.010","article-title":"Diuretic De-escalation in response to HF therapy","volume":"13","author":"Biegus","year":"2025","journal-title":"JACC Heart Fail"},{"key":"B90","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/s41591-024-03374-z","article-title":"Effects of tirzepatide on circulatory overload and end-organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the SUMMIT trial","volume":"31","author":"Borlaug","year":"2025","journal-title":"Nat Med"},{"key":"B91","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.amjcard.2024.07.012","article-title":"Clinical outcomes of metabolic surgery on diuretic use in patients with heart failure","volume":"226","author":"Kachmar","year":"2024","journal-title":"Am J Cardiol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s13679-023-00500-9","article-title":"The fat kidney","volume":"12","author":"Verde","year":"2023","journal-title":"Curr Obes Rep"},{"key":"B93","doi-asserted-by":"publisher","first-page":"4053","DOI":"10.1002\/ehf2.14040","article-title":"Practical management of frailty in older patients with heart failure","volume":"9","author":"Boureau","year":"2022","journal-title":"ESC Heart Fail"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.3390\/jcm14061982","article-title":"Heart failure in older patients: an update","volume":"14","author":"Montalto","year":"2025","journal-title":"J Clin Med"},{"key":"B95","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.hrtlng.2021.05.005","article-title":"Older and younger patients\u2019 perceptions, evaluations, and responses to worsening heart failure symptoms","volume":"50","author":"Lin","year":"2021","journal-title":"Heart Lung J Crit Care"},{"key":"B96","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.hfc.2022.03.002","article-title":"SGLT2 Inhibitors and safety in older patients","volume":"18","author":"Pollack","year":"2022","journal-title":"Heart Fail Clin"},{"key":"B97","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1111\/jgs.18481","article-title":"Frailty and uptake of angiotensin receptor neprilysin inhibitor for heart failure with reduced ejection fraction","volume":"71","author":"Lee","year":"2023","journal-title":"J Am Geriatr Soc"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/S0140-6736(24)01733-1","article-title":"Mineralocorticoid receptor antagonists in heart failure: an individual patient level meta-analysis","volume":"404","author":"Jhund","year":"2024","journal-title":"Lancet Lond Engl"},{"key":"B99","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ejim.2021.03.035","article-title":"The use of \u03b2-blockers in patients with heart failure and comorbidities: doubts, certainties and unsolved issues","volume":"88","author":"Paolillo","year":"2021","journal-title":"Eur J Intern Med"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1731305\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T06:38:09Z","timestamp":1767595089000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1731305\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":99,"alternative-id":["10.3389\/fcvm.2025.1731305"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2025.1731305","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]},"article-number":"1731305"}}